Table 2 Results of the repeated measures ANOVA models for KOOS global score and each subscale, and mean difference and effect size between baseline and 3 months of follow-up – FAS population
Variable | Baseline (n = 32) | After 1 month (n = 28) | After 3 months (n = 26) | P-value | Mean difference (n = 26) | Effect size |
|---|---|---|---|---|---|---|
Global score [mean ± SD] | 45.24 ± 14.93 | 57.56 ± 19.09 | 63.76 ± 20.76 | < 0.0001 | 19.31 ± 16.14 | 1.20 |
Pain* [mean ± SD] | 48.26 ± 16.32 | 61.11 ± 19.74 | 70.09 ± 19.44 | < 0.0001 | 22.44 ± 17.91 | 1.25 |
Symptom [mean ± SD] | 55.58 ± 20.48 | 68.37 ± 20.01 | 73.76 ± 21.26 | < 0.0001 | 18.54 ± 20.40 | 0.91 |
Activity of daily living [mean ± SD] | 54.37 ± 16.96 | 65.23 ± 20.97 | 72.23 ± 20.83 | < 0.0001 | 18.21 ± 13.24 | 1.38 |
Sport and recreation function [mean ± SD] | 25.63 ± 16.40 | 40.18 ± 25.00 | 43.85 ± 28.86 | < 0.0001 | 18.85 ± 22.46 | 0.84 |
Quality of life* [mean ± SD] | 42.38 ± 19.10 | 52.90 ± 20.94 | 58.89 ± 24.95 | < 0.0001 | 18.51 ± 20.35 | 0.91 |